Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaito

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Internal Medicine (Tokyo, Japan)|July 1, 1993
Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNAS Watanabe, Y Kobayashi, M Konishi, et al.
Journal of Medical Virology|February 15, 2001
Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugationN Fujita, M Kaito, S Ishida, et al.
The American Journal of Gastroenterology|June 11, 1999
Mutation of UGT1A1 gene in a case of Crigler-Najjar syndrome type IIT Ishihara, H Sato, S Fukui, et al.
Hepato-Gastroenterology|August 5, 2000
Assessment of portosystemic shunt by summation of radioactivity during 201thallium chloride portal scintigraphy in patients with chronic liver diseaseH Kato, M Kaito, E C Gabazza, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2001
Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation techniqueS Ishida, M Kaito, M Kohara, et al.
Cancer|October 20, 1999
High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinomaN Nakagawa, J Ikoma, T Ishihara, et al.
Journal of Viral Hepatitis|February 16, 2006
Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patientsN Fujita, M Kaito, H Tanaka, et al.
Journal of Clinical Laboratory Analysis|February 20, 1999
Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver diseaseN Kawamura-Yasui, M Kaito, N Nakagawa, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2000
Decrease of regional cerebral blood flow in liver cirrhosisM Iwasa, K Matsumura, M Kaito, et al.
Journal of Medical Virology|July 18, 2000
Biliary excretion of TT virus (TTV)N Nakagawa, J Ikoma, T Ishihara, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Internal Medicine (Tokyo, Japan)|July 1, 1993
Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNAS Watanabe, Y Kobayashi, M Konishi, et al.
Journal of Medical Virology|February 15, 2001
Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugationN Fujita, M Kaito, S Ishida, et al.
The American Journal of Gastroenterology|June 11, 1999
Mutation of UGT1A1 gene in a case of Crigler-Najjar syndrome type IIT Ishihara, H Sato, S Fukui, et al.
Hepato-Gastroenterology|August 5, 2000
Assessment of portosystemic shunt by summation of radioactivity during 201thallium chloride portal scintigraphy in patients with chronic liver diseaseH Kato, M Kaito, E C Gabazza, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 19, 2001
Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation techniqueS Ishida, M Kaito, M Kohara, et al.
Cancer|October 20, 1999
High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinomaN Nakagawa, J Ikoma, T Ishihara, et al.
Journal of Viral Hepatitis|February 16, 2006
Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patientsN Fujita, M Kaito, H Tanaka, et al.
Journal of Clinical Laboratory Analysis|February 20, 1999
Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver diseaseN Kawamura-Yasui, M Kaito, N Nakagawa, et al.
European Journal of Gastroenterology & Hepatology|September 28, 2000
Decrease of regional cerebral blood flow in liver cirrhosisM Iwasa, K Matsumura, M Kaito, et al.
Journal of Medical Virology|July 18, 2000
Biliary excretion of TT virus (TTV)N Nakagawa, J Ikoma, T Ishihara, et al.
Pageof 4